Biologic therapeutics include virus, therapeutic serums, toxins,
allergenic products, antitoxin, blood components or derivatives, vaccines,
blood, and proteins (except any chemically synthesized polypeptide). They also
include analogous products, arsphenamine, or derivatives of arsphenamine (or
any other trivalent organic arsenic compound) for the prevention, treatment, or
cure of a disease. The differences between the biologics and small molecules
include the molecular weight, structure, procedure of synthesis, and
immunogenicity. Biologics have a higher molecular weight and a complex
molecular structure. They are usually derived from living entities, which is
another important feature that differentiates it from small molecules.
Biologics are also vulnerable to extreme temperatures (thermolabile) and light.
Request A Sample copy of This Report @ http://www.hexareports.com/sample/57538
Covered in this report
This report covers the present scenario and the growth prospects of the
global biologic therapeutics market for the period 2015-2019. To calculate the
market size, the report considers revenue generated through the sales protein
therapeutics (monoclonal antibodies, enzymes, and other protein therapeutics).
Other protein therapeutics covers proteins such as cytokines, fusion
proteins, peptide antibiotics, peptide hormones, and blood factors.
The report also presents the vendor landscape and a corresponding
detailed analysis of the top vendors in the market. The vendor landscape
section includes a market share analysis of the major vendors along with the
competitive performances of their product portfolios. In addition, the report
discusses the major drivers that influence the growth of the market. It also
outlines the challenges faced by the vendors and the market at large, as well
as the key trends emerging in the market.
Key regions
Americas
APAC
EMEA
Key vendors
Amgen
F. Hoffmann-La Roche
Novo Nordisk
Sanofi
Other prominent
vendors
AbbVie
AstraZeneca
Bavarian Nordic
Baxter International
Beijing Minhai Biotechnology
Bharat Biotech
Bharat Immunologicals and
Biologicals
Bio Med Pvt.
bioCSL
Biodel
Bristol-Myers Squibb
Diamyd Medical
DiaVacs
Dynavax Technologies
Eli Lilly
Generex Biotechnology
Hualan Biological Engineering
Imunoloski Zavod
Indian Immunologicals
Janssen
JN International Medical
Kaketsuken
LG Life Sciences
Macrogenics
MannKind
Merck
Mitsubishi Tanabe Pharma
Nuron Biotech
Osiris Therapeutics
Pfizer
Protalix
Protein Sciences
Serum Institute of India
Shenzhen Kangtai Biological
Products
Sinovac Biotech
Tolerion
Vacunas Finlay
XOMA
Zydus Cadila
Market driver
Reimbursement support for
biologics
For a full, detailed list, view
our report
Market challenge
High cost of therapy
For a full, detailed list, view
our report
Market trend
Emergence of targeted and
combination therapies
For a full, detailed list, view
our report
Key question
answered in this report
What will the market size be in
2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market
growth?
Who are the key vendors in this
market space?
What are the market opportunities
and threats faced by the key vendors?
What are the strengths and
weaknesses of the key vendors?
Visit Our Website: http://www.hexareports.com/
Contact
Information:
Ryan
Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone
Number
1-800-489-3075
No comments:
Post a Comment